CYCC - Cyclacel Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 517.76M
Enterprise Value 3-3.97M
Trailing P/E N/A
Forward P/E 1-4.00
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.87
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 60.44

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-26.76%
Return on Equity (ttm)-43.74%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-4.24M
Net Income Avi to Common (ttm)-14.64M
Diluted EPS (ttm)-1.53
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)21.73M
Total Cash Per Share (mrq)1.81
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.81
Book Value Per Share (mrq)1.70

Cash Flow Statement

Operating Cash Flow (ttm)-5.81M
Levered Free Cash Flow (ttm)-4.03M

Trading Information

Stock Price History

Beta 1.61
52-Week Change 3-66.82%
S&P500 52-Week Change 313.41%
52 Week High 34.52
52 Week Low 31.28
50-Day Moving Average 31.42
200-Day Moving Average 31.58

Share Statistics

Avg Vol (3 month) 3105.55k
Avg Vol (10 day) 360.33k
Shares Outstanding 512M
Float 9.66M
% Held by Insiders 119.39%
% Held by Institutions 14.74%
Shares Short 3406.63k
Short Ratio 37.86
Short % of Float 34.21%
Shares Short (prior month) 3484.58k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Aug 1, 2016
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/12
Last Split Date 3May 31, 2016